Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BCC 2023 | St. Gallen BCC 2023: translating clinical developments

Philip Poortmans • 16 Mar 2023
BCC 2023
Breast Cancer

Philip Poortmans, MD, PhD, AZ Sint-Augustinus – Oncologisch Centrum GZA – Iridium Kankernetwerk, Antwerpen, Belgium, discusses the importance of the St. Gallen International Breast Cancer Conference on contexualising recent clinical developments in breast cancer. This interview took place at the St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Philip Poortmans

2:41
Controversies and uncertainties in axillary management
Philip Poortmans • 16 Mar 2023
0:28
Controversies in the treatment of the axilla
Philip Poortmans • 16 Mar 2023
1:27
PRADA: evaluating radiotherapy before deep inferior flap reconstruction
Philip Poortmans • 3 May 2022
1:55
A new regimen of hypofractionated postoperative radiation therapy for breast cancer
Philip Poortmans • 3 May 2022

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals